Readystate Asset Management LP Makes New $732,000 Investment in iShares Global Healthcare ETF $IXJ

Readystate Asset Management LP bought a new stake in iShares Global Healthcare ETF (NYSEARCA:IXJ) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 7,822 shares of the company’s stock, valued at approximately $732,000.

Several other hedge funds and other institutional investors have also made changes to their positions in IXJ. Nvest Wealth Strategies Inc. bought a new stake in shares of iShares Global Healthcare ETF in the 4th quarter worth $30,000. Franklin Resources Inc. grew its stake in shares of iShares Global Healthcare ETF by 80.0% in the 2nd quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock worth $31,000 after purchasing an additional 160 shares during the last quarter. Arax Advisory Partners bought a new stake in shares of iShares Global Healthcare ETF in the 4th quarter worth approximately $31,000. LOM Asset Management Ltd raised its holdings in shares of iShares Global Healthcare ETF by 37.0% in the 4th quarter. LOM Asset Management Ltd now owns 407 shares of the company’s stock worth $40,000 after purchasing an additional 110 shares in the last quarter. Finally, Capital Investment Counsel Inc acquired a new stake in iShares Global Healthcare ETF during the fourth quarter valued at approximately $42,000.

iShares Global Healthcare ETF Stock Down 0.4%

Shares of iShares Global Healthcare ETF stock opened at $102.43 on Thursday. The stock’s fifty day moving average is $97.04 and its 200-day moving average is $96.52. The firm has a market capitalization of $4.16 billion, a PE ratio of 21.58 and a beta of 0.57. iShares Global Healthcare ETF has a 12-month low of $82.16 and a 12-month high of $103.40.

iShares Global Healthcare ETF Profile

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.